Home - Invivoscribe

Cat #: 92000020

IdentiClone^® TCRB + TCRG T-Cell Clonality Assay MegaKit – Gel Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92050011

IdentiClone^® TCRB Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92050010

IdentiClone^® TCRB Gene Clonality Assay – Gel Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92050021

IdentiClone^® TCRB Gene Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92050020

IdentiClone^® TCRB Gene Clonality Assay MegaKit – Gel Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92060011

IdentiClone^® TCRD Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92060010

IdentiClone^® TCRD Gene Clonality Assay – Gel Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92060021

IdentiClone^® TCRD Gene Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92070021

IdentiClone^® TCRG Gene Clonality Assay – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92070020

IdentiClone^® TCRG Gene Clonality Assay – Gel Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92070041

IdentiClone^® TCRG Gene Clonality Assay MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92070040

IdentiClone^® TCRG Gene Clonality Assay MegaKit – Gel Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes. These gene rearrangements generate products that are uniq...

View Product

Cat #: 92070101

IdentiClone^® T Cell Receptor Gamma Gene Rearrangement Assay 2.0 – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes and generate products that are unique in length and sequence...

View Product

Cat #: 92070111

IdentiClone^® T Cell Receptor Gamma Gene Rearrangement Assay 2.0 MegaKit – ABI Fluorescence Detection

Rearrangements of the antigen receptor genes occur during ontogeny in B and T lymphocytes and generate products that are unique in length and sequence...

View Product

Cat #: 40920010

IVS-0000 Polyclonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1 mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient...

View Product

Cat #: 40880010

IVS-0001 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40890100

IVS-0002 Clonal Control RNA

This RNA control is adjusted to a final concentration of 400 µg/mL with molecular grade water. The IVS-0002 Clonal Control RNA can be used as a posit...

View Product

Cat #: 40890190

IVS-0003 Clonal Control RNA

This RNA control is adjusted to a final concentration of 400 µg/mL with molecular grade water. The IVS-0003 Clonal Control RNA can be used as a posit...

View Product

Cat #: 40880190

IVS-0004 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Cat #: 40880370

IVS-0007 Clonal Control DNA

This DNA control is adjusted to a final concentration of 200 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient ...

View Product

Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

All Products

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021 Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

All Products

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing